Articles

The word on ‘The Street’ is: Shopping

DDNews' chief editor muses on merger and acquisition trends in pharma and biotech and some films about Wall Street, and ponders whether the big-money M&As are worth it overall (for the industry and the patients)
Written byJeffrey Bouley
| 3 min read

I recently watched “The Wolf of Wall Street” on DVD with my wife and was struck by two things.

One, of course, was its well-earned status of apparently having the most uses of the F-word in a non-documentary film.

The other thing that struck me was how much it reminded me of the 1987 film “Wall Street.” Not in terms of plot, mind you, but rather tone. Although Leonardo DiCaprio’s 2013 portrayal of real-life Jordan Belfort, who engaged in securities fraud, was not Michael Douglas’ fictional Gordon Gekko, a corporate raider who liked to buy up companies and then sell them off in pieces, there is a very strong similarity in terms of their hunger to acquire.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of a multicolored protein structure composed of folded ribbon-like strands against a blue and teal background with scattered spherical particles
Learn how advanced analytical methods support the characterization of antibody–C1q interactions and the qualification of analytical binding assays.